⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25629782 | 0.90 | — | — | |
| SCHEMBL31094811 | 0.80 | — | — | |
| SCHEMBL24424484 | 0.77 | — | — | |
| SCHEMBL24424253 | 0.77 | — | — | |
| SCHEMBL12890033 | 0.76 | — | — | |
| SCHEMBL28896576 | 0.76 | GAA (0.36) | — | |
| SCHEMBL19552005 | 0.74 | — | — | |
| SCHEMBL19567599 | 0.73 | — | — | |
| SCHEMBL12890238 | 0.73 | — | — | |
| SCHEMBL28896079 | 0.72 | GAA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10604507-B2 | Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof | Crinetics Pharmaceuticals, Inc. (US) | 2020-03-31 | — | — | US | disclosed |